7-116775015-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_000245.4(MET):ā€‹c.3163C>Gā€‹(p.Leu1055Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000171 in 1,461,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1055I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.000017 ( 0 hom. )

Consequence

MET
NM_000245.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.17
Variant links:
Genes affected
MET (HGNC:7029): (MET proto-oncogene, receptor tyrosine kinase) This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.2274591).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
METNM_000245.4 linkuse as main transcriptc.3163C>G p.Leu1055Val missense_variant 15/21 ENST00000397752.8
METNM_001127500.3 linkuse as main transcriptc.3217C>G p.Leu1073Val missense_variant 15/21
METNM_001324402.2 linkuse as main transcriptc.1873C>G p.Leu625Val missense_variant 14/20
METXM_011516223.2 linkuse as main transcriptc.3220C>G p.Leu1074Val missense_variant 16/22

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
METENST00000397752.8 linkuse as main transcriptc.3163C>G p.Leu1055Val missense_variant 15/211 NM_000245.4 P3P08581-1
METENST00000318493.11 linkuse as main transcriptc.3217C>G p.Leu1073Val missense_variant 15/211 A2P08581-2
METENST00000436117.3 linkuse as main transcriptc.*768C>G 3_prime_UTR_variant, NMD_transcript_variant 14/201 P08581-3
METENST00000454623.1 linkuse as main transcriptc.418C>G p.Leu140Val missense_variant 3/35

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1461872
Hom.:
0
Cov.:
31
AF XY:
0.0000179
AC XY:
13
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000198
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Renal cell carcinoma Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 11, 2024This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1073 of the MET protein (p.Leu1073Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MET-related conditions. ClinVar contains an entry for this variant (Variation ID: 999912). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MET protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 06, 2023The p.L1073V variant (also known as c.3217C>G), located in coding exon 14 of the MET gene, results from a C to G substitution at nucleotide position 3217. The leucine at codon 1073 is replaced by valine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.099
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.41
T;.;.
Eigen
Benign
-0.026
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.23
T;T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
0.90
L;.;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.087
Sift
Benign
0.20
T;T;D
Sift4G
Benign
0.23
T;T;T
Polyphen
0.0070
B;B;.
Vest4
0.094
MutPred
0.40
Gain of relative solvent accessibility (P = 0.2629);.;.;
MVP
0.43
MPC
0.28
ClinPred
0.54
D
GERP RS
4.6
Varity_R
0.39
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1060503534; hg19: chr7-116415069; API